Page 265 - Read Online

Mondal et al. Neuroimmunol Neuroinflammation 2018;5:34 I http://dx.doi.org/10.20517/2347-8659.2018.13 Page 17 of 19

8. Zagzag D, Salnikow K, Chiriboga L, Yee H, Lan L, Ali MA, Garcia R, Demaria S, Newcomb EW. Downregulation of major
histocompatibility complex antigens in invading glioma cells: stealth invasion of the brain. Lab Invest 2005;85:328-41.
9. Jackson C, Ruzevick J, Phallen J, Belcaid Z, Lim M. Challenges in immunotherapy presented by the glioblastoma multiforme
microenvironment. Clin Dev Immunol 2011;2011:732413.
10. Hao C, Parney IF, Roa WH, Turner J, Petruk KC, Ramsay DA. Cytokine and cytokine receptor mRNA expression in human
glioblastomas: evidence of Th1, Th2 and Th3 cytokine dysregulation. Acta Neuropathol 2002;103:171-8.
11. Chahlavi A, Rayman P, Richmond AL, Biswas K, Zhang R, Vogelbaum M, Tannenbaum C, Barnett G, Finke JH. Glioblastomas induce
T-lymphocyte death by two distinct pathways involving gangliosides and CD70. Cancer Res 2005;65:5428-38.
12. Kast RE, Hill QA, Wion D, Mellstedt H, Focosi D, Karpel-Massler G, Heiland T, Halatsch ME. Glioblastoma-synthesized G-CSF and
GM-CSF contribute to growth and immunosuppression: potential therapeutic benefit from dapsone, fenofibrate, and ribavirin. Tumour
Biol 2017;39:1010428317699797.
13. Kamran N, Kadiyala P, Saxena M, Candolfi M, Li Y, Moreno-Ayala MA, Raja N, Shah D, Lowenstein PR, Castro MG.
Immunosuppressive Myeloid Cells’ Blockade in the glioma microenvironment enhances the efficacy of immune-stimulatory gene
therapy. Mol Ther 2017;25:232-48.
14. Blank U, Karlsson S. TGF-beta signaling in the control of hematopoietic stem cells. Blood 2015;125:3542-50.
15. Chabanon A, Desterke C, Rodenburger E, Clay D, Guerton B, Boutin L, Bennaceur-Griscelli A, Pierre-Louis O, Uzan G, Abecassis
L, Bourgeade MF, Lataillade JJ, Le Bousse-Kerdiles MC. A cross-talk between stromal cell-derived factor-1 and transforming growth
factor-beta controls the quiescence/cycling switch of CD34(+) progenitors through FoxO3 and mammalian target of rapamycin. Stem
Cells 2008;26:3150-61.
16. Bharti AC, Singh SM. Induction of apoptosis in bone marrow cells by gangliosides produced by a T cell lymphoma. Immunol Lett
2000;72:39-48.
17. Bharti AC, Singh SM. Gangliosides derived from a T cell lymphoma inhibit bone marrow cell proliferation and differentiation. Int
Immunopharmacol 2001;1:155-65.
18. Gentile PS, Pelus LM. In vivo modulation of myelopoiesis by prostaglandin E2. IV. Prostaglandin E2 induction of myelopoietic
inhibitory activity. J Immunol 1988;141:2714-20.
19. Kurland J, Moore MA. Modulation of hemopoiesis by prostaglandins. Exp Hematol 1977;5:357-73.
20. Geissler K, Jager E, Ohler L, Gisslinger H, Jager U, Lechner K. Interleukin-10 inhibits autonomous myelopoiesis in patients with
myelofibrosis. Eur J Haematol 2015;95:239-43.
21. Oehler L, Kollars M, Bohle B, Berer A, Reiter E, Lechner K, Geissler K. Interleukin-10 inhibits burst-forming unit-erythroid growth by
suppression of endogenous granulocyte-macrophage colony-stimulating factor production from T cells. Exp Hematol 1999;27:217-23.
22. King KY, Goodell MA. Inflammatory modulation of HSCs: viewing the HSC as a foundation for the immune response. Nat Rev
Immunol 2011;11:685-92.
23. Eskandary H, Basiri M, Nematollahi-Mahani SN, Mehravaran S. The role of stem cells in tumor targeting and growth suppression of
gliomas. Biologics 2011;5:61-70.
24. Kim SH, Kwon CH, Nakano I. Detoxification of oxidative stress in glioma stem cells: mechanism, clinical relevance, and therapeutic
development. J Neurosci Res 2014;92:1419-24.
25. Bradfute SB, Graubert TA, Goodell MA. Roles of Sca-1 in hematopoietic stem/progenitor cell function. Exp Hematol 2005;33:836-43.
26. Deshpande S, Bosbach B, Yozgat Y, Park CY, Moore MA, Besmer P. KIT receptor gain-of-function in hematopoiesis enhances stem cell
self-renewal and promotes progenitor cell expansion. Stem Cells 2013;31:1683-95.
27. Katayama N, Shih JP, Nishikawa S, Kina T, Clark SC, Ogawa M. Stage-specific expression of c-kit protein by murine hematopoietic
progenitors. Blood 1993;82:2353-60.
28. Arai F, Hirao A, Ohmura M, Sato H, Matsuoka S, Takubo K, Ito K, Koh GY, Suda T. Tie2/Angiopoietin-1 signaling regulates
hematopoietic stem cell quiescence in the bone marrow niche. Cell 2004;118:149-61.
29. Ikushima YM, Arai F, Nakamura Y, Hosokawa K, Kubota Y, Hirashima M, Toyama H, Suda T. Enhanced Angpt1/Tie2 signaling affects
the differentiation and long-term repopulation ability of hematopoietic stem cells. Biochem Biophys Res Commun 2013;430:20-5.
30. Springer TA, Dustin ML, Kishimoto TK, Marlin SD. The lymphocyte function-associated LFA-1, CD2, and LFA-3 molecules: cell
adhesion receptors of the immune system. Annu Rev Immunol 1987;5:223-52.
31. Sarkar S, Begum Z, Dutta S, Dutta SK, Chaudhuri S, Chaudhuri S. Sheep form of leucocyte function antigen-3 (T11TS) exerts
immunostimulatory and anti-tumor activity against experimental brain tumor. A new approach to biological response modifier therapy. J
Exp Clin Cancer Res 2002;21:95-106.
32. Giegerich GW, Hein WR, Miyasaka M, Tiefenthaler G, Hunig T. Restricted expression of CD2 among subsets of sheep thymocytes and
T lymphocytes. Immunology 1989;66:354-61.
33. Hunig T, Tiefenthaler G, Mitnacht R, Kohler C, Lottspeich F, Meuer S. The “erythrocyte receptor” of T-lymphocytes and T11 target
structure (T11TS): complementary cell interaction molecules involved in T-cell activation. Behring Inst Mitt 1987:31-40.
34. Kumar P, Chatterjee S, Acharya S, Kumari A, Chaudhuri S, Singh MK, Ghosh SN, Chaudhuri S. Significant modulation of macrophages
associated cytokines TNF-alpha, VEGF and apoptotoic protein Bax, Bcl2 abrogates tumor cells. Cell Immunol 2013;284:172-81.
35. Begum Z, Ghosh A, Sarkar S, Mukherjee J, Mazumdar M, Sarkar P, Chaudhuri S. Documentation of immune profile of microglia
through cell surface marker study in glioma model primed by a novel cell surface glycopeptide T11TS/SLFA-3. Glycoconj J
2004;20:515-23.
36. Bhattacharjee M, Acharya S, Ghosh A, Sarkar P, Chatterjee S, Kumar P, Chaudhuri S. Bax and Bid act in synergy to bring about